Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
20.0%
% of PJP's 30 holdings also in OZEM
25.0%
% of OZEM's 25 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 5.8% | 17.1% | 5.8% |
|
AMGEN INC | 5.1% | 4.2% | 4.2% |
|
PFIZER INC | 5.0% | 3.5% | 3.5% |
|
REGENERON PHARMACEUTICALS | 2.5% | 2.4% | 2.4% |
|
GILEAD SCIENCES INC | 3.3% | 2.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to OZEM
|
ABBOTT LABORATORIES | 5.7% |
|
ABBVIE INC | 5.7% |
|
JOHNSON & JOHNSON | 5.2% |
|
BRISTOL-MYERS SQUIBB CO | 4.7% |
|
MERCK & CO. INC. | 4.4% |
|
LIQUIDIA TECHNOLOGIES, INC. | 3.9% |
|
TRAVERE THERAPEUTICS, INC. | 3.3% |
 |
JAZZ PHARMACEUTICALS PLC | 3.0% |
|
LIGAND PHARMACEUTICALS-CL B | 2.7% |
|
PRESTIGE BRANDS HOLDINGS INC | 2.7% |
PJP Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -14.7% |
|
ELI LILLY & CO | -11.4% |
 |
ROCHE HOLDING LTD | -5.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.7% |
|
ZEALAND PHARMA A/S | -4.4% |
 |
INNOVENT BIOLOGICS, INC. | -4.0% |
 |
HANMI PHARM CO LTD | -3.1% |
|
VIKING THERAPEUTICS, INC. | -2.8% |
|
ALTIMMUNE, INC. | -2.4% |